TGFB2 and colorectal cancer: While not fully characterized in colorectal cancer, inhibition of TGFβ3 in preclinical models of glioblastoma multiforme is associated with decreased expression of downstream SMAD oncogenes, decreased tumor invasiveness, and dampened TGFβ1/TGFβ2 signaling (40).